APA, NCPA praise new state law banning PBMs from owning pharmacies
Arkansas HB 1150 a model for other states, federal government, organizations say.
Pharmacy
Swisslog Healthcare unveils new pharmacy tech
AutoPack, supports up to 480 medications in a single packager.
NACDS applauds Trump executive order, urges swift PBM reforms
NACDS emphasizes the importance of enacting the sound reforms that are ready to go and broadly supported in Congress.
Alliance to End Hunger joins NACDS “Nourish My Health” campaign
“This partnership of like-minded, national organizations is an effective way to harness support and mobilize resources,” said Eric Mitchell, President of the Alliance to End Hunger.
Trump signs order aimed at lowering drug prices
Executive order calls for lowering the costs of life-saving drugs for low-income patients.
The pharmacist’s guide to navigating flu vaccine options
By Dr. Monica Trivedi at Marshall B. Ketchum University
Inmar Intelligence reaches agreement with the DEA
The agreement results from 18 months of collaboration between Inmar and DEA officials to interpret regulations on reverse distribution of controlled substances.
APCI applauds Governor, Legislature for passage of SB 252
SB 252 was crafted to bring long-overdue transparency to prescription drug pricing, ensure fair reimbursement for pharmacies, and rein in abusive PBM practices that have contributed to rising drug costs and the closure of community pharmacies across the state.
AAM issues comments on Section 232 investigation on pharmaceuticals
“AAM and the generics and biosimilars industry look forward to working with the Commerce Department and the White House to engage constructively on ways to incent more domestic investment in the medicines supply chain,” said John Murphy III, president and CEO.
CVS Health Foundation and AACP continue program to reduce barriers for student pharmacists
Scholarships will help reduce financial barriers for student pharmacists.
AAM commends Senate Q1/Q2 bill introduction
Saves more than $800 million over 10 years; brings lower-cost medicines to patients soone
Brian Lawson appointed executive director of the Board of Pharmacy Specialties
Lawson succeeds William Ellis, who retired after 12 years of exemplary leadership as Executive Director of BPS.
Trump planned pharmaceutical tariffs could raise possibility of price hikes, shortages
It’s uncertain whether tariffs will influence more companies to make more drugs in the U.S. like Trump is hoping for, some experts said.
CHPA lauds lawmakers for urging FDA to safeguard Rx-OTC pathway
“It cannot be emphasized enough how vital expanded access to OTC medicines is to public health, and the Rx-to-OTC switch process has delivered safe, effective, and affordable options for decades.”
Camber launches Lurasidone Hydrochloride Tablets
Lurasidone Hydrochloride Tablets are an atypical antipsychotic indicated for the treatment of Schizophrenia in adults and adolescents (13 to 17 years) and other depressive episodes.
Amneal donates $1.5 million to support patients during Parkinson’s Awareness Month
Amneal’s donations will be directed toward programs that offer funding support for out-of-pocket costs—including copayments, coinsurance, and deductibles—for FDA-approved Parkinson’s medications.